Worth reading
42Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
7.9
%Wording
Conditional
How definitive the wording is.Results for this period
Third quarter1 June 2025–28 February 2026ConsolidatedJapanese GAAPNet Sales366,218Millions of yenYear on year +7.9%Progress 74.5%
Operating profit17,110Millions of yenYear on year +4.1%Progress 71.0%
Ordinary income18,036Millions of yenYear on year +6.4%Progress 72.4%
Net income attributable to owners of the parent12,205Millions of yenYear on year +9.1%Progress 74.9%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥188.93
Financial position at period-end
Total assets241,428Millions of yen
of which net assets 149,088 Millions of yenEquity ratio 61.8%vs. prior year-end +1.5pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Regional sales
Kanagawa Prefecture221,56160.5%
Tokyo Metropolitan Government50,28213.7%
Shizuoka Prefecture38,63510.5%
Chiba Prefecture34,4539.4%
Other21,2855.8%
Outlook and shareholder returns
Full-year earnings forecast
Net Sales491,500 Millions of yen (YoY +7.5%)
Operating profit24,100 Millions of yen (YoY +6.5%)
Ordinary income24,900 Millions of yen (YoY +6.3%)
Net income16,300 Millions of yen (YoY +3.9%)
Annual Dividend Forecast¥78 → ¥90
Factors Behind Changes in Business Performance
Existing-store sales exceeded the previous year as EDLP initiatives continued to be implemented. Prescription volumes and average prescription prices remained firm as the number of dispensing pharmacy outlets increased, collaboration with nearby medical institutions was strengthened and the calculation of various add-on fees was expanded. The opening of 21 new drugstores and the increase in stores resulting from 株式会社サンエフ and 株式会社八百半ホールディングス becoming consolidated subsidiaries also contributed.
Disclosure regarding the going concern assumption
No applicable matters
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew Number of companies 3 / Company name 株式会社サンエフ, 株式会社八百半ホールディングス, 株式会社八百半フードセンター / Excluded Number of companies 0 / Company name Not disclosed
Breakdown of extraordinary income (loss)Extraordinary income Item Gain on sale of investment securities / Amount Not disclosed, Item Subsidy Income / Amount 76 Millions of yen, Item Other / Amount 0 Millions of yen / Extraordinary loss Item Loss on sale of fixed assets / Amount Not disclosed, Item Loss on Disposal of Fixed Assets / Amount 0 Millions of yen, Item Loss on reduction of fixed assets / Amount 76 Millions of yen, Item Provision for store closure losses / Amount 10 Millions of yen, Item Provision for contract cancellation losses / Amount Not disclosed, Item Other / Amount Not disclosed
Depreciation and amortization4,663 Millions of yen
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingWhether applicable No / Subject person Not disclosed
Issued Shares at Period-End66,819,342 Shares
Treasury Shares at Period-End2,217,078 Shares
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 June 2025–28 February 2026 |
| Net Sales | 366,218 Millions of yen (YoY +7.9%) |
| Operating profit | 17,110 Millions of yen (YoY +4.1%) |
| Ordinary income | 18,036 Millions of yen (YoY +6.4%) |
| Profit attributable to owners of the parent | 12,205 Millions of yen (YoY +9.1%) |
| Net income per share | ¥188.93 |
| Equity ratio | End of the current fiscal period 61.8 / End of previous period 60.3 |
| Total assets | 241,428 Millions of yen |
| Net assets | 149,088 Millions of yen |
| Full-year earnings forecast | Net Sales 491,500 Millions of yen (YoY +7.5%) / Operating profit 24,100 Millions of yen (YoY +6.5%) / Ordinary income 24,900 Millions of yen (YoY +6.3%) / Net income 16,300 Millions of yen (YoY +3.9%) |
| Annual Dividend Forecast | ¥78 → ¥90 |
| Regional sales | Region Kanagawa Prefecture / Net Sales 221,561 Millions of yen / Composition ratio_pct 60.5, Region Tokyo Metropolitan Government / Net Sales 50,282 Millions of yen / Composition ratio_pct 13.7, Region Shizuoka Prefecture / Net Sales 38,635 Millions of yen / Composition ratio_pct 10.5, Region Chiba Prefecture / Net Sales 34,453 Millions of yen / Composition ratio_pct 9.4, Region Other / Net Sales 21,285 Millions of yen / Composition ratio_pct 5.8 |
| Depreciation and amortization | 4,663 Millions of yen |
| Breakdown of extraordinary income (loss) | Extraordinary income Item Gain on sale of investment securities / Amount Not disclosed, Item Subsidy Income / Amount 76 Millions of yen, Item Other / Amount 0 Millions of yen / Extraordinary loss Item Loss on sale of fixed assets / Amount Not disclosed, Item Loss on Disposal of Fixed Assets / Amount 0 Millions of yen, Item Loss on reduction of fixed assets / Amount 76 Millions of yen, Item Provision for store closure losses / Amount 10 Millions of yen, Item Provision for contract cancellation losses / Amount Not disclosed, Item Other / Amount Not disclosed |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 3 / Company name 株式会社サンエフ, 株式会社八百半ホールディングス, 株式会社八百半フードセンター / Excluded Number of companies 0 / Company name Not disclosed |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | Whether applicable No / Subject person Not disclosed |
| Issued Shares at Period-End | 66,819,342 Shares |
| Treasury Shares at Period-End | 2,217,078 Shares |
| Factors Behind Changes in Business Performance | Existing-store sales exceeded the previous year as EDLP initiatives continued to be implemented. Prescription volumes and average prescription prices remained firm as the number of dispensing pharmacy outlets increased, collaboration with nearby medical institutions was strengthened and the calculation of various add-on fees was expanded. The opening of 21 new drugstores and the increase in stores resulting from 株式会社サンエフ and 株式会社八百半ホールディングス becoming consolidated subsidiaries also contributed. |
Items this document does not state (13)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicySegment revenueSegment profitOrders received and order backlogImpairment lossMaterial subsequent events
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The increase was attributable to existing-store sales exceeding the previous year as EDLP initiatives continued, prescription volumes and average prescription prices remaining firm as the number of dispensing pharmacy outlets increased, collaboration with medical institutions was strengthened and the calculation of various add-on fees was expanded, as well as an increase in stores through new openings and the conversion of companies into subsidiaries.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.